Clinical Trials in Miami

Showing 1541-1560 of 5,521 trials

PK & Safety Study of Xeruborbactam Oral Prodrug Combined With Ceftibuten in Participants With Renal Impairment

NCT06157242

A Phase 1, open-label, single-dose study to determine the safety and pharmacokinetics of ORAvance (ceftibuten/xeruborbactam oral prodrug \[QPX7831\]) in participants with renal impairment

Bacterial Infections

Qpex Biopharma, Inc.32 participantsStarted Nov 2024

Miami, Florida, United States • Orlando, Florida, United States

RECRUITINGPhase 1< 1 mile

APVO436 Phase 1b/2 Study in Patients With Newly Diagnosed AML

NCT06634394

A multi-center, open-label, dose-finding study of five dose levels of APVO436 in combination with venetoclax and azacitidine (ven/aza) in adult patients with newly diagnosed, CD123+ AML.

Acute Myeloid Leukemia (AML)

Aptevo Therapeutics39 participantsStarted Oct 2024

Denver, Colorado, United States • Miami, Florida, United States • Fairway, Kansas, United States +4 more locations

COMPLETEDPhase 4< 1 mile

Adalimumab in JIA-associated Uveitis Stopping Trial

NCT03816397

The proposed study is a stratified, block-randomized, double-masked, controlled trial to determine the feasibility of discontinuing adalimumab treatment in patients with quiescent uveitis associated with juvenile idiopathic arthritis (JIA) or chronic anterior uveitis (CAU).

UveitisJIA

Nisha Acharya87 participantsStarted Mar 2020

Sacramento, California, United States • San Francisco, California, United States • Aurora, Colorado, United States +18 more locations

PK & Safety Study of Xeruborbactam Oral Prodrug Combined With Ceftibuten in Participants With Renal Impairment

APVO436 Phase 1b/2 Study in Patients With Newly Diagnosed AML

Adalimumab in JIA-associated Uveitis Stopping Trial

Find Trials by Condition in Miami

Study of Adagloxad Simolenin (OBI-822)/OBI-821 in the Adjuvant Treatment of Patients With Globo H Positive TNBC

Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)

A Phase I Study of KB301, a Replication-Incompetent, Non-Integrating Vector Expressing Human Type III Collagen (COL3) for the Treatment of Superficial Skin Depressions

Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery

Safety and Efficacy Study of reSept ASD Occluder for Treating Secundum ASD

Effects of a Theanine for Stress Relief Formulation in Individuals Who Report Occasional Moderate High Levels of Stress.

PRV-3279-2a Trial in Systemic Lupus

Phase II Study to Evaluate Efficacy and Safety of D-0120 in Combination With Allopurinol in Subjects With Gout

STEM-Parkinson's Disease

The Percutaneous Transmural Arterial Bypass -1 Study (Post Approval Registry)

A Trial Evaluating the Safety and Effects of an RNA Vaccine ARCT-021 in Healthy Adults

Dose-Ranging Study of ST-920, an AAV2/6 Human Alpha Galactosidase A Gene Therapy in Subjects With Fabry Disease (STAAR)

A Study of IMR-687 in Subjects With Sickle Cell Disease

Extension Study to Evaluate the Long-Term Outcomes of Pediatric Patients Who Received Treatment for Retinopathy of Prematurity in the VGFTe-ROP-1920 Study (Acronym: Butterfleye Next)

Savolitinib Plus Durvalumab Versus Sunitinib and Durvalumab Monotherapy in MET-Driven, Unresectable and Locally Advanced or Metastatic PRCC

Natural Sunlight Protection and Simulated Sunlight Protection Offered by Sunscreens and Fabrics

SIRT Followed by CIS-GEM Chemotherapy Versus CIS-GEM Chemotherapy Alone as 1st Line Treatment of Patients With Unresectable Intrahepatic Cholangiocarcinoma